TG Therapeutics, Inc. (TGTX) stock analysis

In our weekly check, TG Therapeutics, Inc. is graded C (A to F). Of 23 checks on debt, profit, cash flow and trend: 15 pass, warnings: 4, red flags: 4.

About TG Therapeutics, Inc.

TG Therapeutics, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as TGTX.

What our checks show for TGTX

Red flags

Warning signs

Strengths

Similar companies

SYRE · MDGL · PCVX · PRAX · KRYS · KYMR

Questions

What grade does TG Therapeutics, Inc. (TGTX) have?

In our weekly check, TG Therapeutics, Inc. is graded C (A to F). Of 23 checks on debt, profit, cash flow and trend: 15 pass, warnings: 4, red flags: 4. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of TGTX stock?

This week's biggest flags for TG Therapeutics, Inc.: Gross margin falling, Deep past fall, High beta. In total 8 of 23 checks show a warning or a red flag.

What does TG Therapeutics, Inc. do?

TG Therapeutics, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as TGTX.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis